Becton, Dickinson and Company Share Price

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 19/04/2024 BST 5-day change 1st Jan Change
234.1 USD +0.42% Intraday chart for Becton, Dickinson and Company -0.45% -3.98%
Sales 2024 * 20.31B 1,642B Sales 2025 * 21.5B 1,738B Capitalization 67.64B 5,468B
Net income 2024 * 2.11B 171B Net income 2025 * 2.63B 212B EV / Sales 2024 * 3.96 x
Net Debt 2024 * 12.83B 1,037B Net Debt 2025 * 10.55B 853B EV / Sales 2025 * 3.64 x
P/E ratio 2024 *
34.8 x
P/E ratio 2025 *
28.2 x
Employees 73,000
Yield 2024 *
1.59%
Yield 2025 *
1.62%
Free-Float 77.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.42%
1 week-0.45%
Current month-5.39%
1 month-2.55%
3 months-0.75%
6 months-9.07%
Current year-3.98%
More quotes
1 week
229.40
Extreme 229.395
238.07
1 month
229.40
Extreme 229.395
248.42
Current year
229.40
Extreme 229.395
249.89
1 year
229.40
Extreme 229.395
287.32
3 years
215.90
Extreme 215.9
287.32
5 years
197.75
Extreme 197.75
287.32
10 years
111.07
Extreme 111.07
287.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 31/12/08
Director of Finance/CFO 52 05/09/21
Chief Tech/Sci/R&D Officer 48 31/12/18
Members of the board TitleAgeSince
Director/Board Member 73 23/09/02
Director/Board Member 73 28/01/13
Director/Board Member 69 25/07/10
More insiders
Date Price Change Volume
19/04/24 234.1 +0.42% 1,265,166
18/04/24 233.2 +0.40% 891,669
17/04/24 232.2 +0.52% 1,510,566
16/04/24 231 -1.58% 1,064,150
15/04/24 234.7 -0.19% 872,266

Delayed Quote Nyse, April 19, 2024 at 09:00 pm

More quotes
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
234.1 USD
Average target price
281.2 USD
Spread / Average Target
+20.12%
Consensus